EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated multi-omics analysis reveals distinct microbiota-metabolite signatures and a novel HCN2-2-hydroxybutyric acid interaction in inflammatory bowel disease

Menghui Zhang, Jingjing Jiang, Bo Yang, Wenzhuo Zhao, Jialing Zhang, Tianheng Ma, Honggang Wang

Frontiers in Nutrition · 23.06.2026 · 13

DOI: 10.3389/fnut.2026.1843166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 23.06.2026. Verfasst von Menghui Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu Province, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gut microbiota-derived short-chain fatty acids (SCFAs) exert critical regulatory functions in inflammatory bowel disease (IBD). However, integrated profiling of fecal SCFA signatures alongside gut microbiota composition in ulcerative colitis (UC) and Crohn's disease (CD) remains insufficiently characterized. Furthermore, the molecular mechanisms through which microbiota metabolites engage host protein targets warrant systematic investigation.

Methods

This study enrolled 30 patients with UC, 20 with CD, and 30 healthy controls, with paired fecal collection. Gut microbiota composition was analyzed by deep metagenomic sequencing, and SCFA concentrations were quantified by gas chromatography-mass spectrometry. Multi-omics integration, correlation network analysis, and Bayesian kernel machine regression were employed to resolve microbiota-metabolite associations. An integrated computational pipeline incorporating molecular dynamics simulations was constructed to evaluate the thermodynamic stability and binding modalities of metabolite-protein interactions.

Results

Both UC and CD patients exhibited significantly reduced gut microbial α-diversity and characteristic community structure alterations. Fecal metabolomic profiling revealed synchronous elevation of 2-Hydroxybutyric acid (2-HB) and isocaproate in both patient groups, whereas butyrate reduction was restricted to UC. Multi-omics correlation analysis identified significant associations between 2-HB and unclassified Veillonella species as well as specific functional modules. Molecular dynamics simulations with an aggregate sampling time of 100 ns revealed a structural basis for the formation of a stable complex between 2-HB and the hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2). This interaction was primarily mediated by electrostatic interactions involving Arg659, Arg618, and Arg617 residues alongside hydrophobic contacts, suggestive of potential allosteric modulation.

Conclusions

This study identifies 2-HB and isocaproate as shared fecal metabolic markers across IBD and provides a structural rationale for the interaction between 2-HB and HCN2. The druggability profile of HCN2 supports its prioritization for mechanistic investigation, with the caveat that functional validation is prerequisite to any inference of therapeutic relevance.

Schlagwörter

Stichwörter der Autor:innen

2-HBHCN2gut microbiotainflammatory bowel diseasemulti-omicsshort-chain fatty acids

Autor:innen und Institutionen

  • Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu Province, China.

Zitieren

APA

Zhang, M., Jiang, J., Yang, B., Zhao, W., Zhang, J., Ma, T., & Wang, H. (2026). Integrated multi-omics analysis reveals distinct microbiota-metabolite signatures and a novel HCN2-2-hydroxybutyric acid interaction in inflammatory bowel disease. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1843166

Vancouver

Zhang M, Jiang J, Yang B, Zhao W, Zhang J, Ma T, et al. Integrated multi-omics analysis reveals distinct microbiota-metabolite signatures and a novel HCN2-2-hydroxybutyric acid interaction in inflammatory bowel disease. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1843166

BibTeX
@article{Zhang2026,
  author = {Zhang, Menghui and Jiang, Jingjing and Yang, Bo and Zhao, Wenzhuo and Zhang, Jialing and Ma, Tianheng and Wang, Honggang},
  title = {Integrated multi-omics analysis reveals distinct microbiota-metabolite signatures and a novel HCN2-2-hydroxybutyric acid interaction in inflammatory bowel disease},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1843166}
}
Kostenlos starten →